Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07201389) titled 'CARE (Chemotherapy Alopecia REduction)' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: George Washington University
Condition:
Breast Cancer
Breast - Female
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III
Chemotherapy Induced Alopecia
Intervention:
Device: Scalp Cooling by DigniCap
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 24, 2025
Target Sample Size: 30
Countries of Recruitment:
United States
To know ...